Medication adherence in patients with diabetes and dyslipidemia: Associated factors and strategies for improvement

Current Cardiology Reports

Volumn 15, Issue 11, 2013, Pages

  Marzec, Lucas N ^a   Maddox, Thomas M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Dyslipidemia; Medication non adherence

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLITAZONE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; METFORMIN PLUS ROSIGLITAZONE; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; ANTIDIABETIC AGENT;

ARTICLE; DIABETES MELLITUS; DOCTOR PATIENT RELATION; DRUG COST; DRUG SAFETY; DYSLIPIDEMIA; HEALTH BEHAVIOR; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH LITERACY; HUMAN; HYPOGLYCEMIA; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; POLYPHARMACY; RACE DIFFERENCE; RISK FACTOR; SOCIOECONOMICS; ATHEROSCLEROSIS; ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; HEALTH CARE COST; PATIENT EDUCATION; PREVALENCE; PSYCHOLOGY; UNITED STATES;

ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DYSLIPIDEMIAS; HEALTH EXPENDITURES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH LITERACY; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES;

MLCS; MLOWN;

EID: 84886914146     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0418-7     Document Type: Article

References (42)

1. O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc. 1998;73:969-76. (Pubitemid 28467699)
2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360, 7-22.
3. Kearney PM et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371:117-25. (Pubitemid 351697949)
4. Tourkmani AM et al. Medication adherence among patients in a chronic disease clinic. Saudi Med J. 2012;33:1278-84.
5. Zhang Q, Zhao C, Davies MJ, Radican L, Seck T. Compliance and persistence with concomitant statin and oral antihyperglycemic therapy. Am J Manag Care. 2011;17:746-52. 2011.
6. De Geest S, Sabaté E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;2:323. (Pubitemid 37518223)
7. • Schroeder EB et al. Simultaneous Control of Diabetes Mellitus, Hypertension, and Hyperlipidemia in 2 Health Systems. Circ Cardiovasc Qual Outcomes. 2012;5:645-53. Important recent description of poor rates of simultaneous control of multiple chronic medical conditions. Highlights the challenges faced in management of diabetes with other coincident medical conditions.
8. Wallach-Kildemoes H, Andersen M, Diderichsen F, Lange T. Adherence to preventive statin therapy according to socioeconomic position. Eur J Clin Pharmacol. 2013. doi: 10.1007/s00228-013-1488-6.
9. Saffar D, Williams K, Lafata JE, Divine G, Pladevall M. Racial disparities in lipid control in patients with diabetes. Am J Manag Care. 2012;18:303-11.
10. Marcum ZA et al. Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. Res Soc Adm Pharm Rsap. 2013. doi: 10.1016/j.sapharm.2012. 12.002.
11. Hunt KJ et al. Impact of diabetes control on mortality by race in a national cohort of veterans. Ann Epidemiol. 2013;23:74-9.
12. Jackevicius CA, Li P, Tu JV. Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction. Circulation. 2008;117:1028-36.
13. Lee HY, Cooke CE, Robertson TA. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm. 2008;14:271-80. (Pubitemid 351711978)
14. Sanfélix-Gimeno G et al. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in valencia, Spain. J Manag Care Pharm. 2013;19:247-57.
15. Natarajan N, Putnam W, Van Aarsen K, Beverley Lawson K, Burge F. Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician Méd Fam Can. 2013;59:e93-e100.
16. Choudhry NK et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365:2088-97.
17. • Williams J, Steers WN, Ettner SL, Mangione CM, Duru OK. Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes. Med Care. 2013;51:193-8. Describes a significant rate of cost-related medication non-adherence in patients with diabetes mellitus enrolled in Medicare Part D plans.
18. Paes AHP, Bakker A, Soe-Agnie CJ. Impact of Dosage Frequency on Patient Compliance. Dia Care. 1997;20:1512-7. (Pubitemid 27415025)
19. Dailey G, Kim MS, Lian JF. Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus. Clin Ther. 2001;23:1311-20. (Pubitemid 32804123)
20. Laliberté F et al. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Adv Ther. 2012;29:675-90.
21. Alvarez Guisasola F et al. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab. 2008;10 Suppl 1:25-32.
22. Hauber AB, Mohamed AF, Johnson FR, Falvey H. Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents. Diabet Med J Br Diabet Assoc. 2009;26:416-24.
23. Osborn CY et al. Health literacy explains racial disparities in diabetes medication adherence. J Health Commun. 2011;16 Suppl 3:268-78.
24. Loke YK, Hinz I, Wang X, Salter C. Systematic Review of Consistency Between Adherence to Cardiovascular or Diabetes Medication and Health Literacy in Older Adults. Ann Pharmacother. 2012;46:863-72.
25. Bauer AM et al. Health Literacy and Antidepressant Medication Adherence Among Adults with Diabetes: The Diabetes Study of Northern California (DISTANCE). J Gen Intern Med. 2013. doi: 10.1007/s11606-013-2402-8.
26. Grodensky CA, Golin CE, Ochtera RD, Turner BJ. Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. J Stud Alcohol Drugs. 2012;73:899-910.
27. Bryson CL et al. Alcohol Screening Scores and Medication Nonadherence. Ann Intern Med. 2008;149:795-W165.
28. Osborn CY, Egede LE. The relationship between depressive symptoms and medication nonadherence in type 2 diabetes: the role of social support. Gen Hosp Psychiatry. 2012;34:249-53.
29. Amar J, Ferrières J, Cambou J-P, Amelineau E, Danchin N. Persistence of combination of evidence-based medical therapy in patients with acute coronary syndromes. Arch Cardiovasc Dis. 2008;101:301-6.
30. Al-Omran M et al. Suboptimal use of statin therapy in elderly patients with atherosclerosis: A population-based study. J Vasc Surg. 2008;48:607-612.e1.
31. Farmer A, Kinmonth A-L, Sutton S. Measuring beliefs about taking hypoglycaemic medication among people with Type 2 diabetes. Diabet Med. 2006;23:265-70.
32. Sirey JA, Greenfield A, Weinberger MI, Bruce ML. Medication Beliefs and Self-Reported Adherence Among Community-Dwelling Older Adults. Clin Ther. 2013;35:153-60.
33. Walker RJ et al. Effect of diabetes fatalism on medication adherence and self-care behaviors in adults with diabetes. Gen Hosp Psychiatry. 2012;34:598-603.
34. Carter SR, Moles R, White L, Chen TF. Medication information seeking behavior of patients who use multiple medicines: How does it affect adherence? Patient Educ Couns. 2013. doi: 10.1016/j.pec.2013.01.019.
35. Ratanawongsa N et al. Communication and medication refill adherence: the Diabetes Study of Northern California. Jama Intern Med. 2013;173:210-8.
36. Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: A retrospective database analysis. Clin Ther. 2004;26:2066-75. (Pubitemid 40353616)
37. Hutchins V, Zhang B, Fleurence RL, Krishnarajah G, Graham J. A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes. Curr Med Res Opin. 2011;27:1157-68.
38. Scanlon DP et al. Financial and Clinical Impact of Team-Based Treatment for Medicaid Enrollees With Diabetes in a Federally Qualified Health Center. Dia Care. 2008;31:2160-5. 2008.
39. Nieuwkerk PT et al. Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk. Am J Cardiol. 2012;110:666-72.
40. Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm. 2012;18:516-26.
41. Lin EHB et al. Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial. Ann Fam Med. 2012;10:6-14.
42. • Elliott DJ, Robinson EJ, Anthony KB, Stillman PL. Patient-centered outcomes of a value-based insurance design program for patients with diabetes. Popul Heal Manag. 2013;16:99-106. Prospective cohort study demonstrating a value-based insurance plan is associated with an improvement in patient-reported medication adherence.